BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3883944)

  • 1. Quality assurance and proficiency testing for autoantibodies to nuclear antigen.
    Nakamura RM; Rippey JH
    Arch Pathol Lab Med; 1985 Feb; 109(2):109-14. PubMed ID: 3883944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
    Warlow R; Carrano J; Dawkins R
    Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus.
    Reeves WH; Chaudhary N; Salerno A; Blobel G
    J Exp Med; 1987 Mar; 165(3):750-62. PubMed ID: 3546581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies against ds-DNA and nucleoprotein in systemic lupus erythematosus--comparison of various determinative methods].
    Geissler K; Graninger W
    Z Rheumatol; 1985; 44(6):254-8. PubMed ID: 3913215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the laboratory accreditation programme of the College of American Pathologists.
    Abu-Amero KK
    East Mediterr Health J; 2002; 8(4-5):654-63. PubMed ID: 15603049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to nuclear lamin B in a patient with thrombopenia.
    Guilly MN; Danon F; Brouet JC; Bornens M; Courvalin JC
    Eur J Cell Biol; 1987 Apr; 43(2):266-72. PubMed ID: 3297706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of assays for the detection of antibodies to rubella. A report based on data from the College of American Pathologists Surveys of 1982.
    Skendzel LP; Wilcox KR; Edson DC
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):594-8. PubMed ID: 6353907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.
    Fritzler MJ; Wiik A; Tan EM; Smolen JS; McDougal JS; Chan EK; Gordon TP; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wilson M; Byrd MG; Slivka L; Koziol JA
    J Rheumatol; 2003 Nov; 30(11):2374-81. PubMed ID: 14677180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of rubella testing: a report based on data from the College of American Pathologists' surveys, 1978-1980.
    Skendzel LP
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):547-53. PubMed ID: 7025612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
    Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
    Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
    J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to extractable nuclear antigens in systemic lupus erythematosus].
    Ivanova SM; Alekberova ZS; Preobrazhenskiĭ DV; Speranskiĭ AI
    Ter Arkh; 1982; 54(6):54-7. PubMed ID: 7112420
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent progress in the study of autoantibodies to nuclear antigens.
    Nakamura RM; Tan EM
    Hum Pathol; 1978 Jan; 9(1):85-91. PubMed ID: 344192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 15. The stability of survey-assigned assay values when surveyed control materials are used in a daily interlaboratory quality control program. The College of American Pathologists Chemistry Survey--Quality Assurance Service shared pool experience.
    Lawson PL; Lawson NS; Ross JW
    Arch Pathol Lab Med; 1995 Apr; 119(4):312-33. PubMed ID: 7726725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
    Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
    J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Variability in Immunofluorescence Titer of Antibodies to Nuclear Antigens Observed in Clinical Laboratory Proficiency Testing Surveys.
    Wener MH; Fink S; Bashleben C; Sindelar S; Linden MA
    Arch Pathol Lab Med; 2021 Aug; 145(8):937-942. PubMed ID: 33373439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performances of urine pregnancy tests on College of American Pathologists Survey specimens.
    Biesecker JL; Rippey JH
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):544-6. PubMed ID: 7282640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MBL quality control survey of autoantibodies--25 years of activity and its achievement--mainly antinuclear antibodies].
    Tsunekawa S; Arai J; Ishihara Y; Fujii Y
    Rinsho Byori; 2010 Feb; 58(2):131-8. PubMed ID: 20229811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.